Diagnostic & Therapeutic Center Of Athens Hygeia Single Member S.A.

The medical center is at the forefront of cardiology research, focusing on innovative treatments for myocardial infarction and heart failure. The center's research aims to improve outcomes for patients with reduced left ventricular ejection fraction following a heart attack.

• Myocardial Infarction
• Acute Heart Failure
• Left Sided Heart Failure

By exploring novel therapeutic agents, the center contributes to the development of advanced treatment protocols that enhance cardiac function and patient quality of life.

Specializing in metabolic disorders, the center conducts pivotal research on conditions such as severe hypertriglyceridemia. The focus is on evaluating the safety and efficacy of new treatments to manage lipid levels and reduce cardiovascular risk.

• Severe Hypertriglyceridemia

Through its research, the center aims to provide groundbreaking insights into the management of lipid disorders, offering hope for improved therapeutic strategies.

The center is a leader in oncology research, particularly in the treatment of endometrial cancer and other gynecological malignancies. It explores the efficacy of novel immunotherapies and targeted treatments to improve patient outcomes.

• Endometrial Cancer
• Ovarian Cancer
• Cervical Cancer

By advancing the understanding of cancer biology and treatment response, the center plays a crucial role in the development of personalized cancer therapies.

Focusing on gynecologic oncology, the center investigates treatments for platinum-sensitive and platinum-resistant ovarian cancer. Research includes evaluating combination therapies to enhance progression-free survival.

• Platinum-sensitive Ovarian Cancer
• Platinum-resistant Ovarian Cancer

The center's work in this area aims to refine therapeutic approaches, offering new hope for patients with challenging gynecological cancers.

In the realm of breast cancer, the center is dedicated to exploring advanced treatment options for hormone receptor positive and inoperable breast cancers. The research focuses on comparing novel agents with standard chemotherapy to improve survival rates.

• Hormone Receptor Positive Breast Cancer

Through its innovative research, the center seeks to transform breast cancer treatment paradigms, enhancing therapeutic efficacy and patient outcomes.